Article citationsMore>>

Rezai-Zadeh, K., Arendash, G.W., Hou, H., Fernandez, F., Jensen, M., Runfeldt, M., Tan, J., et al. (2008) Green Tea Epigallocatechin-3-Gallate (EGCG) Reduces β-Amyloid Mediated Cognitive Impairment and Modulates Tau Pathology in Alzheimer Transgenic Mice. Brain Research, 1214, 177-187.
https://doi.org/10.1016/j.brainres.2008.02.107

has been cited by the following article:

• TITLE: Research Progress on the Therapeutic Mechanism of Tea Polyphenols in Neurodegenerative Diseases

  AUTHORS: Zhenying Yu, Hongyan Wu

  KEYWORDS: Neurodegenerative Diseases, Tea Polyphenols, Neuroprotection

  JOURNAL NAME: Journal of Biosciences and Medicines, Vol.11 No.11, November 8, 2023

  ABSTRACT: In recent years, the incidence of neurodegenerative diseases, mainly Alzheimer’s disease, Parkinson’s disease, vascular dementia, and cerebral ischemia, has been rising gradually, which has a serious impact on the physiological state and quality of life of human beings in old age, and the current clinical drugs are unsatisfactory in terms of therapeutic efficacy and healing, which has made this kind of diseases become a social medical problem. Tea polyphenols are the main functional components of tea and have great potential in neuroprotection. In this paper, we review the research on tea polyphenols in neurodegenerative diseases, with the aim of providing a new entry point for the treatment of neurodegenerative diseases.